Filing Flows › Usana Health Sciences (USNA) › Free cash flow
Usana Health Sciences (USNA) free cash flow by quarter
Usana Health Sciences' free cash flow was $20.2M in Q2 2026 (second quarter 2026), +183% from Q1 2026. Over the last 5 quarters it ranged from $4.0M (Q4 2024) to $20.2M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $20.2M | +183% | +180% |
| Q1 2026 | $7.1M | -1% | -44% |
| Q2 2025 | $7.2M | -43% | — |
| Q1 2025 | $12.7M | +218% | — |
| Q4 2024 | $4.0M | — | — |
Q2 2026 at a glance
Usana Health Sciences, Q2 2026: revenue $223M (-5% year over year), operating margin -9.0%, net loss $28.0M, operating cash flow $23.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Usana Health Sciences' free cash flow?
Usana Health Sciences' free cash flow was $20.2M in Q2 2026 (second quarter 2026), +183% from Q1 2026.
How has Usana Health Sciences' free cash flow changed?
Over the last 5 quarters it ranged from $4.0M (Q4 2024) to $20.2M (Q2 2026).